Angelo Scopelianos, VP Research & Development at Axogen, Inc. (AXGN), sold 567 shares at $17.81 ($10K) on 2020-12-29, disclosed to the SEC on 2020-12-30.
Open-market sale of $10k AXGN by VP Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.